UCL Discovery
UCL home » Library Services » Electronic resources » UCL Discovery

RDH12 retinopathy: clinical features, biology, genetics and future directions

Daich Varela, Malena; Michaelides, Michel; (2022) RDH12 retinopathy: clinical features, biology, genetics and future directions. Ophthalmic Genetics pp. 1-6. 10.1080/13816810.2022.2062392. (In press). Green open access

[thumbnail of RDH12 retinopathy clinical features biology genetics and future directions.pdf]
Preview
Text
RDH12 retinopathy clinical features biology genetics and future directions.pdf - Published Version

Download (4MB) | Preview

Abstract

Retinol dehydrogenase 12 (RDH12) is a small gene located on chromosome 14, encoding an enzyme capable of metabolizing retinoids. It is primarily located in photoreceptor inner segments and thereby is believed to have an important role in clearing excessive retinal and other toxic aldehydes produced by light exposure. Clinical features: RDH12-associated retinopathy has wide phenotypic variability; including early-onset severe retinal dystrophy/Leber Congenital Amaurosis (EOSRD/LCA; most frequent presentation), retinitis pigmentosa, cone-rod dystrophy, and macular dystrophy. It can be inherited in an autosomal recessive and dominant fashion. RDH12-EOSRD/LCA's key features are early visual impairment, petal-shaped, coloboma-like macular atrophy with variegated watercolour-like pattern, peripapillary sparing, and often dense bone spicule pigmentation. Future directions: There is currently no treatment available for RDH12-retinopathy. However, extensive preclinical investigations and an ongoing prospective natural history study are preparing the necessary foundation to design and establish forthcoming clinical trials. Herein, we will concisely review pathophysiology, molecular genetics, clinical features, and discuss therapeutic approaches.

Type: Article
Title: RDH12 retinopathy: clinical features, biology, genetics and future directions
Location: England
Open access status: An open access version is available from UCL Discovery
DOI: 10.1080/13816810.2022.2062392
Publisher version: https://doi.org/10.1080/13816810.2022.2062392
Language: English
Additional information: © 2022 The Author(s). Published with license by Taylor & Francis Group, LLC. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/).
Keywords: LCA, RDH12, early onset severe retinal dystrophy, gene therapy, molecular genetics, retinal dystrophy
UCL classification: UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Brain Sciences
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Brain Sciences > Institute of Ophthalmology
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences
UCL
URI: https://discovery.ucl.ac.uk/id/eprint/10147947
Downloads since deposit
108Downloads
Download activity - last month
Download activity - last 12 months
Downloads by country - last 12 months

Archive Staff Only

View Item View Item